KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Change in Inventory (2016 - 2025)

Opko Health (OPK) has disclosed Change in Inventory for 16 consecutive years, with -$1.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory fell 152.48% year-over-year to -$1.2 million, compared with a TTM value of $4.1 million through Dec 2025, up 197.65%, and an annual FY2025 reading of $4.1 million, up 197.65% over the prior year.
  • Change in Inventory was -$1.2 million for Q4 2025 at Opko Health, down from -$624000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $27.9 million in Q1 2021 and bottomed at -$24.1 million in Q2 2021.
  • Average Change in Inventory over 5 years is -$3.0 million, with a median of -$1.4 million recorded in 2023.
  • The sharpest move saw Change in Inventory crashed 373.38% in 2023, then skyrocketed 339.09% in 2025.
  • Year by year, Change in Inventory stood at -$16.4 million in 2021, then soared by 85.71% to -$2.3 million in 2022, then plummeted by 373.38% to -$11.1 million in 2023, then surged by 120.11% to $2.2 million in 2024, then crashed by 152.48% to -$1.2 million in 2025.
  • Business Quant data shows Change in Inventory for OPK at -$1.2 million in Q4 2025, -$624000.0 in Q3 2025, and $478000.0 in Q2 2025.